Latest news with #ElectronicClinicalOutcomeAssessment
Yahoo
19-05-2025
- Business
- Yahoo
eCOA Solutions Market worth US$4.78 billion by 2030 with 16.1% CAGR
DELRAY BEACH, Fla., May 19, 2025 /PRNewswire/ -- The global eCOA solution market, valued at US$1.94 billion in 2024, is forecasted to grow at a robust CAGR of 16.1%, reaching US$2.27 billion in 2025 and an impressive US$4.78 billion by 2030. This growth is primarily driven by increasing investments in research and development from medical device companies looking for digital endpoints. Additionally, the growing use of connected devices facilitates real-time data capture in healthcare settings. There is also a heightened need to speed up clinical trial timelines and shift towards patient-centric research, which is driving demand for electronic Clinical Outcome Assessment (eCOA) platforms that allow for remote and direct reporting from patients. Moreover, the need for greater data accuracy and real-time reporting is a key factor, as sponsors aim to reduce transcription errors and ensure high-quality outcome measures. Regulatory bodies are promoting digital adoption by providing clearer guidance on software validation and post-market monitoring, helping to mitigate risks associated with eCOA implementations. Finally, the emergence of decentralized and hybrid trial designs has created opportunities for lightweight, mobile eCOA solutions, enabling continuous data collection outside traditional trial sites. Download PDF Brochure: Browse in-depth TOC on "Electronic Clinical Outcome Assessment Solutions Market" 434 - Tables 54 - Figures 413 - Pages By Deployment Model, the wearables, mobile devices, and other devices market are divided into the bring your own device (BYOD) models, provisioned device models, and hybrid models. The BYOD models segment accounted for the largest market share in 2024. The growth of the BYOD (Bring Your Own Device) market is primarily driven by cost-effectiveness, as it eliminates the need for sponsors to manage dedicated devices, lowering trial costs. Patient familiarity with their devices enhances user-friendliness, boosting engagement and data quality while increasing accessibility for geographically dispersed and resource-limited patients, aligning with decentralized trials. Additionally, technological advancements in secure data encryption address security concerns, and evolving regulations favor secure BYOD implementation in certain regions, positioning it as a cost-efficient, patient-centric approach in clinical trials. By application, the Electronic Clinical Outcome Assessment (eCOA) Solutions market is segmented into clinical trials, observational studies & real-world evidence (RWE) generation, patient management & registries, and other applications. Among these, observational studies & real-world evidence generation are the fastest growing in the Electronic Clinical Outcome Assessment (eCOA) Solutions market within the forecast period. The key factors driving the market growth include the increasing emphasis on the significance of real-world data in healthcare decision-making. Moreover, the growing acceptance of real-world evidence (RWE) by regulatory bodies, healthcare providers, and pharmaceutical companies is also expected to fuel market growth. RWE is crucial for understanding a treatment's effectiveness, safety, and overall impact on patients in everyday clinical practice. By geography, The Electronic Clinical Outcome Assessment (eCOA) Solutions market is segmented into five regional segments: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America accounted for the largest share of the Electronic Clinical Outcome Assessment (eCOA) Solutions market. This region is home to numerous pharmaceutical and biotechnology companies that utilize electronic Clinical Outcome Assessment (eCOA) solutions. These companies conduct extensive clinical trials, aiming for efficient and accurate data collection methods to meet stringent regulatory standards. Additionally, North America's well-established healthcare infrastructure and the high level of digital literacy among healthcare professionals facilitate the smooth integration of eCOA technologies. Furthermore, the region's research and development leadership and significant investments in healthcare technology solidify its position at the forefront of the eCOA market. Request Sample Pages : The electronic clinical outcome assessment (eCOA) solutions market is consolidated and is dominated by key players. The key players operating in this market include IQVIA (US), Medidata (US), ICON Plc (Ireland), Signant Health (US), Clario (US), Oracle Corporation (US), Medable Inc. (US), Merative (US), Parexel International (MA) Corporation (US), Climedo Health GmbH (Germany), Healthentia (Belgium), Veeva Systems (US), assisTek (US), Curebase Inc. (US), Castor (US), EvidentIQ Group GmbH (Germany), YPrime, LLC (US), Clinical Ink (US), Clinion (US), Kayentis (France), TransPerfect (US), ObvioHealth USA, Inc. (US), WCG Clinical (Germany), ClinCapture (US), and Cloudbyz (US). IQVIA HOLDINGS INC. (US) IQVIA is the leading player in the eCOA solutions market. The company's leading position in the market can be attributed to various factors, such as its robust technology and service capabilities, good client relationships, diversified service offerings, and its ability to enhance the penetration of its offerings through significant R&D expenditure and product innovation. IQVIA focuses on product launches, agreements & partnerships to sustain its market position. The company has a wide geographical presence in over 100 countries across North America, Europe, Asia, Latin America, and Africa. The company has the largest and most comprehensive collection of healthcare data globally, including over 1.2 billion comprehensive prescription and promotional datasets, patient records, electronic medical records, genomic datasets, and datasets from social media. Medidata (US): Medidata is one of the leading providers of cloud-based solutions for clinical trials. The company offers a comprehensive suite of eCOA solutions to streamline data collection and improve patient engagement in clinical research. As part of its business overview, Medidata emphasizes its commitment to revolutionizing the way clinical trials are conducted by harnessing the power of technology to enhance efficiency, accuracy, and patient-centricity. The company's strong position in the market is due to its research capabilities and innovative product portfolio. Medidata has offices and facilities across North America, Europe, Asia Pacific, and Latin America. These offices serve as hubs for sales, customer support, research & development, and other business functions, allowing Medidata to serve customers and partners across different regions effectively. For more information, Inquire Now! Related Reports: Healthcare IT Market Clinical Trial Services Market Wearable Healthcare Devices Market mHealth Solutions Market Healthcare Analytics Market Get access to the latest updates on eCOA Solution Companies and eCOA Solution Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC. 1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content to download multimedia: SOURCE MarketsandMarkets Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19-05-2025
- Business
- Yahoo
eCOA Solutions Market worth US$4.78 billion by 2030 with 16.1% CAGR
DELRAY BEACH, Fla., May 19, 2025 /PRNewswire/ -- The global eCOA solution market, valued at US$1.94 billion in 2024, is forecasted to grow at a robust CAGR of 16.1%, reaching US$2.27 billion in 2025 and an impressive US$4.78 billion by 2030. This growth is primarily driven by increasing investments in research and development from medical device companies looking for digital endpoints. Additionally, the growing use of connected devices facilitates real-time data capture in healthcare settings. There is also a heightened need to speed up clinical trial timelines and shift towards patient-centric research, which is driving demand for electronic Clinical Outcome Assessment (eCOA) platforms that allow for remote and direct reporting from patients. Moreover, the need for greater data accuracy and real-time reporting is a key factor, as sponsors aim to reduce transcription errors and ensure high-quality outcome measures. Regulatory bodies are promoting digital adoption by providing clearer guidance on software validation and post-market monitoring, helping to mitigate risks associated with eCOA implementations. Finally, the emergence of decentralized and hybrid trial designs has created opportunities for lightweight, mobile eCOA solutions, enabling continuous data collection outside traditional trial sites. Download PDF Brochure: Browse in-depth TOC on "Electronic Clinical Outcome Assessment Solutions Market" 434 - Tables 54 - Figures 413 - Pages By Deployment Model, the wearables, mobile devices, and other devices market are divided into the bring your own device (BYOD) models, provisioned device models, and hybrid models. The BYOD models segment accounted for the largest market share in 2024. The growth of the BYOD (Bring Your Own Device) market is primarily driven by cost-effectiveness, as it eliminates the need for sponsors to manage dedicated devices, lowering trial costs. Patient familiarity with their devices enhances user-friendliness, boosting engagement and data quality while increasing accessibility for geographically dispersed and resource-limited patients, aligning with decentralized trials. Additionally, technological advancements in secure data encryption address security concerns, and evolving regulations favor secure BYOD implementation in certain regions, positioning it as a cost-efficient, patient-centric approach in clinical trials. By application, the Electronic Clinical Outcome Assessment (eCOA) Solutions market is segmented into clinical trials, observational studies & real-world evidence (RWE) generation, patient management & registries, and other applications. Among these, observational studies & real-world evidence generation are the fastest growing in the Electronic Clinical Outcome Assessment (eCOA) Solutions market within the forecast period. The key factors driving the market growth include the increasing emphasis on the significance of real-world data in healthcare decision-making. Moreover, the growing acceptance of real-world evidence (RWE) by regulatory bodies, healthcare providers, and pharmaceutical companies is also expected to fuel market growth. RWE is crucial for understanding a treatment's effectiveness, safety, and overall impact on patients in everyday clinical practice. By geography, The Electronic Clinical Outcome Assessment (eCOA) Solutions market is segmented into five regional segments: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America accounted for the largest share of the Electronic Clinical Outcome Assessment (eCOA) Solutions market. This region is home to numerous pharmaceutical and biotechnology companies that utilize electronic Clinical Outcome Assessment (eCOA) solutions. These companies conduct extensive clinical trials, aiming for efficient and accurate data collection methods to meet stringent regulatory standards. Additionally, North America's well-established healthcare infrastructure and the high level of digital literacy among healthcare professionals facilitate the smooth integration of eCOA technologies. Furthermore, the region's research and development leadership and significant investments in healthcare technology solidify its position at the forefront of the eCOA market. Request Sample Pages : The electronic clinical outcome assessment (eCOA) solutions market is consolidated and is dominated by key players. The key players operating in this market include IQVIA (US), Medidata (US), ICON Plc (Ireland), Signant Health (US), Clario (US), Oracle Corporation (US), Medable Inc. (US), Merative (US), Parexel International (MA) Corporation (US), Climedo Health GmbH (Germany), Healthentia (Belgium), Veeva Systems (US), assisTek (US), Curebase Inc. (US), Castor (US), EvidentIQ Group GmbH (Germany), YPrime, LLC (US), Clinical Ink (US), Clinion (US), Kayentis (France), TransPerfect (US), ObvioHealth USA, Inc. (US), WCG Clinical (Germany), ClinCapture (US), and Cloudbyz (US). IQVIA HOLDINGS INC. (US) IQVIA is the leading player in the eCOA solutions market. The company's leading position in the market can be attributed to various factors, such as its robust technology and service capabilities, good client relationships, diversified service offerings, and its ability to enhance the penetration of its offerings through significant R&D expenditure and product innovation. IQVIA focuses on product launches, agreements & partnerships to sustain its market position. The company has a wide geographical presence in over 100 countries across North America, Europe, Asia, Latin America, and Africa. The company has the largest and most comprehensive collection of healthcare data globally, including over 1.2 billion comprehensive prescription and promotional datasets, patient records, electronic medical records, genomic datasets, and datasets from social media. Medidata (US): Medidata is one of the leading providers of cloud-based solutions for clinical trials. The company offers a comprehensive suite of eCOA solutions to streamline data collection and improve patient engagement in clinical research. As part of its business overview, Medidata emphasizes its commitment to revolutionizing the way clinical trials are conducted by harnessing the power of technology to enhance efficiency, accuracy, and patient-centricity. The company's strong position in the market is due to its research capabilities and innovative product portfolio. Medidata has offices and facilities across North America, Europe, Asia Pacific, and Latin America. These offices serve as hubs for sales, customer support, research & development, and other business functions, allowing Medidata to serve customers and partners across different regions effectively. For more information, Inquire Now! Related Reports: Healthcare IT Market Clinical Trial Services Market Wearable Healthcare Devices Market mHealth Solutions Market Healthcare Analytics Market Get access to the latest updates on eCOA Solution Companies and eCOA Solution Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC. 1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content to download multimedia: SOURCE MarketsandMarkets Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Globe and Mail
18-02-2025
- Business
- Globe and Mail
E-Clinical Outcome Assessment Solutions Market: Size, Share, and Trends
"The electronic clinical outcome assessment solutions market is poised for continued expansion, driven by technological innovations, shifting regulatory policies, and the growing demand for more efficient and patient-centric clinical trial processes." The electronic clinical outcome assessment (eCOA) solutions market has witnessed substantial growth in recent years, with an increasing adoption of technology in clinical trials. Factors driving this growth include the rising prevalence of chronic diseases, the need for efficient data collection methods, and the benefits of eCOA solutions in improving patient engagement and compliance. Electronic Clinical Outcome Assessment (eCOA) Solution Market in terms of revenue was estimated to be worth $1.8 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 16.6% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the Electronic Clinical Outcome Assessment (eCOA) Solutions market is driven by rise in patient centricity, increase in incidences of chronic disorders, and growing acceptance of eCOA solutions by several pharmaceutical and biotechnology companies for data collection and its analysis. As eCOA helps enhance patient engagement by facilitating patient-reported outcomes. Moreover, the increase in demand for real-world evidence across may boost the market during the forecast period. But the increase in concerns about data breaches and privacy may pose a challenge to the Electronic Clinical Outcome Assessment (eCOA) Solutions market during the forecast period. Download an Illustrative overview: Hybrid model is the fastest growing in the Electronic Clinical Outcome Assessment (eCOA) Solutions market in 2023. Based on component, the Electronic Clinical Outcome Assessment (eCOA) Solutions market is segmented into software, services, and wearable, mobile & other devices. The wearable, mobile & other devices segment is further categorized into bring your own device model (BYOD), Provisioned device model, and hybrid model. The hybrid model is the fastest growing in Electronic Clinical Outcome Assessment (eCOA) Solutions market in 2023 attributing to its ability to offer a balanced and flexible approach to data collection in clinical trials. The hybrid model combines elements of both Bring Your Own Device (BYOD) and Provisioned Device models, providing a versatile solution that accommodates varying preferences and trial requirements. Hybrid model gives flexibility to the participants by offering option to use their own devices or devices provided by the study, depending on their comfort and accessibility. This flexibility reduces barriers to participation, as participants can choose the mode that aligns with their technological preferences. By application, observational studies and real-world evidence generation is the fastest growing in the Electronic Clinical Outcome Assessment (eCOA) Solutions market in 2023. Based on application, the Electronic Clinical Outcome Assessment (eCOA) Solutions market is segmented into clinical trials, observational studies and real-world evidence (RWE) generation, patient management and registries, and other applications. Among these the observational studies and real-world evidence generation is the fastest growing in the Electronic Clinical Outcome Assessment (eCOA) Solutions market in 2023 attributing to an increasing emphasis on real-world data's significance in healthcare decision-making. Moreover, the segment's growth is due to the growing acceptance of real-world evidence (RWE) by regulatory bodies, healthcare providers, and pharmaceutical companies drives. RWE is crucial for understanding a treatment's effectiveness, safety, and overall impact on patients in everyday clinical practice. Pharmaceuticals and biotechnology companies are the largest end users of the Electronic Clinical Outcome Assessment (eCOA) Solutions market in 2023. Based on end users, the Electronic Clinical Outcome Assessment (eCOA) Solutions market is segmented into pharmaceutical & biotechnology companies, contract research organizations (CROs), medtech companies, government organizations, research centers & academic institutes, hospitals & healthcare providers, and consulting service companies. The pharmaceutical and biotechnology companies dominated the eCOA solutions market in 2023 attributing to growth in adoption of eCOA solution across by companies. As the Electronic Clinical Outcome Assessment (eCOA) slutions helps in advancing clinical trials by streamlining and enhancing the accuracy of data collection. Moreover, eCOA also helps to ensure the integrity of clinical data, facilitating regulatory compliance and improving overall study quality. For pharmaceutical and biotechnology firms, the adoption of eCOA translates into accelerated decision-making, reduced trial timelines, and enhanced patient engagement, thus these end users are dominating the market. North America dominates the global Electronic Clinical Outcome Assessment (eCOA) Solutions market in 2023. The Electronic Clinical Outcome Assessment (eCOA) Solutions market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa. In 2023, North America accounted for the largest share of the Electronic Clinical Outcome Assessment (eCOA) Solutions market. As this region is home to a significant number of pharmaceutical and biotechnology companies which are using eCOA solutions. These companies conduct extensive clinical trials, seeking efficient and accurate methods of data collection to meet rigorous regulatory standards. Moreover, the well-established healthcare infrastructure in North America, coupled with a high level of digital literacy among healthcare professionals, facilitates the seamless integration of eCOA technologies. Furthermore, the region's leadership in research and development, coupled with substantial investments in healthcare technology, reinforces its position at the forefront of the eCOA market. Request Sample Pages: The electronic clinical outcome assessment (eCOA) solutions market is consolidated and is dominated by key players. The major players operating in this market IQVIA (US), Medidata (US), ICON Plc (Ireland), Signant Health (US), Clario (US), Oracle Corporation (US), Medable Inc. (US), Merative (US), Parexel International (MA) Corporation (US), Climedo Health GmbH (Germany), Healthentia (Belgium), Veeva Systems (US), assisTek (US), Curebase Inc. (US), Castor (US), EvidentIQ Group GmbH (Germany), YPrime, LLC (US), Clinical Ink (US), Clinion (US), Kayentis (France), TransPerfect (US), ObvioHealth USA, Inc. (US), WCG Clinical (Germany), ClinCapture (US), and Cloudbyz (US). IQVIA HOLDINGS INC, (US) IQVIA is the leading player in the eCOA solutions market. The company's leading position in the market can be attributed to various factors, such as its robust technology and service capabilities, good client relationships, diversified service offerings, and its ability to enhance the penetration of its offerings through significant R&D expenditure and product innovation. IQVIA focuses on product launches and agreements & partnerships to sustain its market position. The company has a wide geographical presence in over 100 countries across North America, Europe, Asia, Latin America, and Africa. The company has the largest and most comprehensive collection of healthcare data across the globe, including over 1.2 billion comprehensive prescription and promotional datasets, patient records, electronic medical records, genomic datasets, and datasets from social media. Medidata (US) Medidata is one of the leading providers of cloud-based solutions for clinical trials. The company offers a comprehensive suite of eCOA solutions designed to streamline data collection and improve patient engagement in clinical research. As part of its business overview, Medidata emphasizes its commitment to revolutionizing the way clinical trials are conducted by harnessing the power of technology to enhance efficiency, accuracy, and patient-centricity. The company's strong position in the market is due to its research capabilities and innovative product portfolio. In fiscal year 2022, the company's research & development expenses increased by 15.5% from USD 949 million in 2021 to USD 1,087 million in 2022, representing 19.2% of its net sales. Medidata has offices and facilities across North America, Europe, Asia Pacific, and Latin America. These offices serve as hubs for sales, customer support, research & development, and other business functions, allowing Medidata to effectively serve customers and partners across different regions. Get 10% Free Customization on this Report: Electronic Clinical Outcome Assessment (eCOA) Solution Market - Key Benefits of Buying the Report: The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies. This report provides insights into the following pointers: Analysis of key drivers (increasing R&D expenditure for product development by medtech, and pharma-biotech companies, rising operational costs and regulatory requirements associated with clinical research studies, favorable government support and funding for clinical trials, growing prevalence of chronic diseases & subsequent increase in clinical trials, effective monitoring of clinical data, reduction in overall costs and timelines of clinical trials), restraints (lack of skilled professionals to develop and operate eCOA solutions, high implementation and maintenance cost, lack of awareness about eCOA solutions among end users), opportunities (surging eCOA adoption owing to increasing number of clinical trials in emerging economies, growing outsourcing of clinical trial processes to CROs, gradual shift from manual data interpretation to real-time data analysis, growing penetration of mobile technology in healthcare industry), and challenges (evolving regulatory landscape and compliance requirements, interoperability & integration, data security & privacy issues, resistance from traditional healthcare professionals and concerns regarding software reliability) influencing the growth of electronic clinical outcome assessment (eCOA) solutions market. Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the electronic clinical outcome assessment (eCOA) solutions market. Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of electronic clinical outcome assessment (eCOA) solutions solutions across regions. Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the electronic clinical outcome assessment (eCOA) solutions market. Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the electronic clinical outcome assessment (eCOA) solutions market.
